慢性肾脏病中的骨与矿物质紊乱:对普通人群心血管健康与老龄化的意义
本文为综述,论述慢性肾脏病(CKD)是动脉硬化、血管钙化和骨病的极端模型,这些病变也与普通人群老龄化相关。CKD相关矿物质骨紊乱(CKD-MBD)研究中的磷酸盐、成纤维细胞生长因子23、甲状旁腺激素、硬骨素和维生素D等分子,可能有助于解释普通人群残余心血管事件风险,并为动脉硬化和骨质疏松的未来治疗提供启示。
要点
- CKD是动脉硬化、血管钙化和骨病的极端模型,这些病变也与普通人群老龄化相关。
- CKD-MBD相关分子(磷酸盐、FGF23、PTH、硬骨素、维生素D)可能解释普通人群残余心血管风险。
- 深入理解CKD-MBD或可为普通人群动脉硬化和骨质疏松的未来治疗提供启示。
核心结论
- 深入理解CKD-MBD可为普通人群动脉硬化和骨质疏松的未来治疗提供重要启示,这些疾病与老龄化和发病率强烈相关。
研究设计与样本
- 本文为综述,未报告系统检索范围。
主要发现
- CKD患者是动脉硬化、血管钙化和骨病的极端模型,这些病理特征也与普通人群老龄化相关。
- CKD应被视为一种非典型疾病,传统和新型心血管危险因素均影响其结局,CKD也可概念化为传统心血管危险因素的加速器。
- CKD-MBD研究中的磷酸盐、成纤维细胞生长因子23、甲状旁腺激素、硬骨素和维生素D等分子,可能有助于解释普通人群残余心血管事件风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The patient with chronic kidney disease (CKD) represents an extreme model for arteriosclerosis, vascular calcification, and bone disorders, all of which are also associated with ageing in the general population. These pathological features are also relevant to other common chronic health disorders such as diabetes, and chronic inflammatory and cardiovascular diseases. Although management and interventions for these major risk factors are now incorporated into most public health guidelines (eg, smoking cessation and control of bodyweight and blood pressure, as well as glucose and cholesterol concentrations), some residual cardiovascular risk is not reduced by implementation of these interventions. CKD should be regarded as an atypical disease in which both traditional and novel cardiovascular risk factors have effects on outcomes. But CKD can also be viewed conceptually as an accelerator of traditional cardiovascular risk factors. Findings from research into mineral bone disorder associated with CKD (CKD-MBD) could help the medical community to better understand the vascular actions of certain molecules, such as phosphates, fibroblast growth factor 23, parathyroid hormone, sclerostin, or vitamin D and their relevance to the management of different pathologies in the general population. Importantly, these components, which are recognised in nephrology, could help to explain residual risk of cardiovascular events in the general population. Thus, achieving a better understanding of CKD-MBDs could provide substantial insight into future treatments for arteriosclerosis and osteoporosis, which are strongly associated with ageing and morbidity in the general population.
引用
- Covic A, Vervloet M, Massy ZA, et al. Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. Lancet Diabetes Endocrinol. 2017. PMID: 29050900. doi:10.1016/S2213-8587(17)30310-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。